Literature DB >> 20708795

Angiogenesis induced by controlled release of neuropeptide substance P.

Hiroshi Kohara1, Shuhei Tajima, Masaya Yamamoto, Yasuhiko Tabata.   

Abstract

The in vivo recruitment of circulating host cells to the site to be regenerated is one of the promising strategies for therapeutic angiogenesis. Substance P (SP), a member of neuropeptides, mediates pain perception and regulates wound healing, inflammation, tumor cell proliferation, and angiogenesis. This SP enhanced the migration, adhesion, and angiogenic gene expression of granulocytes in vitro. A biodegradable hydrogel was prepared from an anionic derivative of gelatin to achieve the controlled release of SP in vivo. When the anionic gelatin hydrogels incorporating SP were subcutaneously implanted into the mouse back, significant angiogenesis was induced around the site implanted, in contrast to the injection of SP solution. In vivo accumulation of granulocytes around the implanted sites was observed. It is concluded that the controlled release of SP efficiently induced the recruitment and the subsequent activation of granulocytes, one of the circulating cells with angiogenic activities, from the blood circulation into the site implanted, resulting in enhanced angiogenesis.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20708795     DOI: 10.1016/j.biomaterials.2010.07.079

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  25 in total

1.  Substance P affects growth factors in Pseudomonas aeruginosa-infected mouse cornea.

Authors:  Megan E B Foldenauer; Sharon A McClellan; Ronald P Barrett; Yunfan Zhang; Linda D Hazlett
Journal:  Cornea       Date:  2012-10       Impact factor: 2.651

2.  Investigation of the effect of homocysteinylation of substance P on its binding to the NK1 receptor using molecular dynamics simulation.

Authors:  Samira Davoudmanesh; Jafar Mohammadian Mosaabadi
Journal:  J Mol Model       Date:  2018-06-26       Impact factor: 1.810

Review 3.  Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.

Authors:  Susmit Suvas
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

4.  Self-assembling peptide nanofibers coupled with neuropeptide substance P for bone tissue engineering.

Authors:  Su Hee Kim; Woojune Hur; Ji Eun Kim; Hye Jeong Min; Sukwha Kim; Hye Sook Min; Byeung Kyu Kim; Soo Hyun Kim; Tae Hyun Choi; Youngmee Jung
Journal:  Tissue Eng Part A       Date:  2015-01-13       Impact factor: 3.845

5.  The effect of Substance P/Heparin conjugated PLCL polymer coating of bioinert ePTFE vascular grafts on the recruitment of both ECs and SMCs for accelerated regeneration.

Authors:  Donghak Kim; Justin J Chung; Youngmee Jung; Soo Hyun Kim
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

Review 6.  Autonomic nerve dysfunction and impaired diabetic wound healing: The role of neuropeptides.

Authors:  Georgios Theocharidis; Aristidis Veves
Journal:  Auton Neurosci       Date:  2019-11-26       Impact factor: 3.145

Review 7.  Neuropeptide substance P and the immune response.

Authors:  Alireza Mashaghi; Anna Marmalidou; Mohsen Tehrani; Peter M Grace; Charalabos Pothoulakis; Reza Dana
Journal:  Cell Mol Life Sci       Date:  2016-06-17       Impact factor: 9.261

Review 8.  Skin neurogenic inflammation.

Authors:  Jae Eun Choi; Anna Di Nardo
Journal:  Semin Immunopathol       Date:  2018-04-30       Impact factor: 9.623

Review 9.  Cutaneous innervation in impaired diabetic wound healing.

Authors:  Nicole C Nowak; Daniela M Menichella; Richard Miller; Amy S Paller
Journal:  Transl Res       Date:  2021-05-23       Impact factor: 10.171

10.  Development and Evaluation of Hyaluronic Acid-Based Hybrid Bio-Ink for Tissue Regeneration.

Authors:  Jaeyeon Lee; Se-Hwan Lee; Byung Soo Kim; Young-Sam Cho; Yongdoo Park
Journal:  Tissue Eng Regen Med       Date:  2018-09-21       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.